# Long-term Follow-up of RESTORE Study

> **NCT05647785** · — · UNKNOWN · sponsor: **Blue Note Therapeutics** · enrollment: 350 (estimated)

## Conditions studied

- Cancer

## Interventions

- **DEVICE:** Long-term follow-up of cerena™
- **DEVICE:** Long-term follow-up of attune™

## Key facts

- **NCT ID:** NCT05647785
- **Lead sponsor:** Blue Note Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-31
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-06-30
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2022-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05647785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05647785, "Long-term Follow-up of RESTORE Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05647785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*